DexCom, Inc.
Financial Performance
DexCom Revenue & Financials
Revenue
$3.6B (FY2023)
Market Cap
$32.5B
Net Income
$541M
Employees
9,600
What is DexCom's revenue?
DexCom had $3.6B in revenue for fiscal year 2023, up 24.3% from 2022. Net income was $541M.
- Latest revenue
- $3.6B (FY2023)
- Year-over-year
- +24.3%
- Growth rate (CAGR)
- 34.3% over 9 years
- Peak revenue
- $3.6B (FY2023)
- Years of data
- 10
- Employees
- 9,600
- How much profit does DexCom make?
- DexCom reported net income of $541M for fiscal year 2023.
- How many employees does DexCom have?
- DexCom has about 9,600 employees.
Financial Analysis
In FY2024, Best Buy generated $43.45 billion in total revenue and $1.24 billion in GAAP net income, generating over $2.1 billion in operating cash flow while returning over $1.1 billion to shareholders via dividends and share repurchases.
Revenue Trend Analysis
YoY Change
+24.3%
9-Year CAGR
+34.3%
Peak Year
2023
Trend
Consistent Growth
DexCom, Inc. has 10 full fiscal year figures on this page, compounding at +34.3% annually over 9 years. The most recent year saw a 24.3% increase versus the prior year. Annual revenue peaked in fiscal year 2023 at $3.6B. Of 9 comparable year-over-year steps, 9 showed growth and 0 showed a decline.
Annual revenue history
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2023 | $3.6B | $541M | +24.3% |
| FY2022 | $2.9B | $345M | +18.8% |
| FY2021 | $2.5B | $294M | +27.2% |
| FY2020 | $1.9B | $236M | +30.2% |
| FY2019 | $1.5B | $181M | +43.5% |
| FY2018 | $1B | $82M | +43.5% |
| FY2017 | $719M | -$95M | +25.3% |
| FY2016 | $574M | -$128M | +42.1% |
| FY2015 | $404M | -$110M | +58.4% |
| FY2014 | $255M | -$74M | — |
Click any row to see year details.
Keep researching DexCom
DexCom Revenue and Financial FAQ
What was Dexcom's latest reported annual revenue?
In its latest audited financial reporting period, Dexcom recorded consolidated net revenue of .62B, demonstrating durable revenue growth across its primary operating divisions.
How profitable is Dexcom?
Dexcom generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings and superior return on equity (ROE) throughout changing economic cycles.
What is Dexcom's capital and liquidity position?
Dexcom maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and capital adequacy ratios that provide substantial safety margins above statutory regulatory requirements.
Does Dexcom distribute capital to shareholders?
Dexcom executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "DexCom Revenue & Financials." CorpDigest, https://corpdigest.com/company/dexcom/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>DexCom reported $3.6B in revenue (FY2023).</strong><br>Source: <a href="https://corpdigest.com/company/dexcom/financials" target="_blank" rel="noopener">CorpDigest — DexCom financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore DexCom
Core profile pages, founders and related research hubs for this company.